Y-Intercept (HK)’s iShares Biotechnology ETF IBB Stock Holding History

Y-Intercept (HK)’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-30,280	Closed	-$5.76M	–	1798
2026 Q2	$5.76M	Buy	+30,280	New	+$5.2M	0.11%	239
2025 Q1	–	Sell	-3,863	Closed	-$511K	–	1384
2024 Q4	$511K	Buy	+3,863	New	+$543K	0.03%	713
2024 Q2	–	Sell	-1,824	Closed	-$250K	–	1613
2024 Q1	$250K	Buy	+1,824	New	+$249K	0.02%	1053
2021 Q4	–	Sell	-6,857	Closed	-$1.11M	–	705
2021 Q3	$1.11M	Buy	6,857 +3,918	+133%	+$659K	0.2%	162
2021 Q2	$481K	Sell	2,939 -1,532	-34%	-$236K	0.12%	273
2021 Q1	$656K	Buy	+4,471	New	+$710K	0.18%	186

Other funds holding IBB

Albion Financial Group Salt Lake City, Utah $1.77B AUM 14.95% 1-Year Est. Return

Generali Investments CEE Prague, Czech Republic $2.11B AUM 18.35% 1-Year Est. Return

MinichMacGregor Wealth Management Saratoga Springs, New York $620M AUM 32.35% 1-Year Est. Return

Investment House LLC Redondo Beach, California $2.25B AUM 30.44% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Old National Bancorp Evansville, Indiana $5.07B AUM 22.07% 1-Year Est. Return

Redstone Wealth Management Oklahoma City, Oklahoma $159M AUM 31.94% 1-Year Est. Return

Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.18B AUM 27.44% 1-Year Est. Return

Decker Retirement Planning Levi, Utah $302M AUM 70.25% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return

Y-Intercept (HK)'s IBB Position: Q3 2026 in Review

Y-Intercept (HK) sold out of iShares Biotechnology ETF (IBB) in Q3 2026, closing a stake of 30,280 shares — an estimated $5.76M sold.

Y-Intercept (HK) first reported a position in IBB in Q1 2021 and held it in 6 quarters. The position peaked at $5.76M in Q2 2026. 265 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

Y-Intercept (HK) reported no remaining iShares Biotechnology ETF position as of Q3 2026 after selling out during the quarter.
Y-Intercept (HK) sold 30,280 iShares Biotechnology ETF shares in Q3 2026, an estimated $5.76M.
Y-Intercept (HK) first reported a position in iShares Biotechnology ETF in Q1 2021 and held it in 6 quarters.
Y-Intercept (HK)'s iShares Biotechnology ETF position peaked at $5.76M in Q2 2026.
265 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.